Hydrogen Research Study
← Back to Research Library
Preclinical animal evidenceAnimal studyOther or not reported

A hydrogen-releasing polydopamine palladium hydride nanocoating protects airway mucosal injury induced by endotracheal tube cuff compression

Guo Mu, Huyang Du, Shuai Chen, Xinyu Chen, Qiang Li, Xuan Yu, Bin Lu, Yi Liu, Cheng Zhang · Biomaterials advances · 2026

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Respiratory and Lung Health
Evidence type Preclinical animal evidence
Publication type Animal study
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

In an animal model, the coating significantly reduced malondialdehyde and nitric oxide levels, enhanced superoxide dismutase activity, and protected mitochondrial integrity and cytoskeletal structure. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.

What the Findings Mean

H2HUBB reviewed how molecular hydrogen was evaluated in this publication and summarizes the source-grounded findings below. The coating significantly reduced malondialdehyde and nitric oxide levels, enhanced superoxide dismutase activity, and protected mitochondrial integrity and cytoskeletal structure.

What the Researchers Studied

The study used a preclinical animal experiment.

What Effects Did Molecular Hydrogen Have?

In in vitro oxygen-glucose deprivation/reoxygenation (OGD/R) cell models using BEAS-2B human bronchial epithelial cells, the PDA-PdH coating (12.25 μg/mL) demonstrated selective scavenging of hydroxyl radicals and hydrogen peroxide while preserving beneficial superoxide species. The coating significantly reduced malondialdehyde and nitric oxide levels, enhanced superoxide dismutase activity, and protected mitochondrial integrity and cytoskeletal structure.

Why These Findings Matter

These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.

How Strong Is This Evidence?

This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.

Technical Study Details

H2HUBB classifies this publication as animal study with preclinical animal evidence. The study used a preclinical animal experiment.

Limitations and Safety

No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.

Original Study and H2HUBB Research Context

H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.